Intellipharmaceutics International, Inc. (IPCIQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Intellipharmaceutics International Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2023 | -1.889M |
| May 31, 2023 | -0.0541M |
| February 28, 2023 | -0.3557M |
| November 30, 2022 | -0.8747M |
| August 31, 2022 | -0.296M |
| May 31, 2022 | -0.8407M |
| February 28, 2022 | -0.881M |
| November 30, 2021 | -1.956M |
| August 31, 2021 | -1.264M |
| May 31, 2021 | -1.000M |
| February 28, 2021 | -0.9246M |
| November 30, 2020 | -1.622M |
| August 31, 2020 | 1.027M |
| May 31, 2020 | -1.048M |
| February 29, 2020 | -1.747M |
| November 30, 2019 | -1.333M |
| August 31, 2019 | -1.454M |
| May 31, 2019 | -2.073M |
| February 28, 2019 | -3.224M |
| November 30, 2018 | -3.784M |
| August 31, 2018 | -3.954M |
| May 31, 2018 | -2.859M |
| February 28, 2018 | -3.150M |
| November 30, 2017 | -2.511M |
| August 31, 2017 | -2.550M |
| Date | Value |
|---|---|
| May 31, 2017 | -1.805M |
| February 28, 2017 | -1.991M |
| November 30, 2016 | -3.913M |
| August 31, 2016 | -2.110M |
| May 31, 2016 | -2.000M |
| February 29, 2016 | -2.12M |
| November 30, 2015 | -3.133M |
| August 31, 2015 | -1.882M |
| May 31, 2015 | -1.507M |
| February 28, 2015 | -0.9147M |
| November 30, 2014 | -1.247M |
| August 31, 2014 | -1.670M |
| May 31, 2014 | -3.140M |
| February 28, 2014 | 2.201M |
| November 30, 2013 | -6.325M |
| August 31, 2013 | -2.048M |
| May 31, 2013 | -1.782M |
| February 28, 2013 | -1.344M |
| November 30, 2012 | -1.384M |
| August 31, 2012 | -1.458M |
| May 31, 2012 | -1.358M |
| February 29, 2012 | -1.936M |
| November 30, 2011 | -1.285M |
| August 31, 2011 | 1.097M |
| May 31, 2011 | -1.969M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abattis Bioceuticals Corp. | -- |
| InMed Pharmaceuticals, Inc. | -4.843M |
| Tetra Bio-Pharma, Inc. | -- |
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |